Malignant Melanoma is one of the few cancers with a rising incidence in the United States. It is curable in its early stages, but advanced disease is associated with a poor prognosis. After decades of therapeutic futility, better understanding of the molecular biology of this disease has led to breakthroughs in drug development in melanoma. In 2011, two new drugs were approved by the US FDA for the treatment of advanced melanoma. This activity aims to disseminate information about the optimal integration of new agents in the current management of melanoma. Similarly, changes in our understanding of the prognostic indicators in melanoma (e.g., pathology, sentinel node mapping) will be highlighted in this activity as it directly impacts clinical practice and will enable the attendee to apply this information in specific patient cases.
Following this program, participants should be able to: 1) Improve their ability to plan a tailored therapeutic strategy in melanoma (early-stage and advanced-stage)2) Identify the selective indications for specialized treatments in melanoma and integrate this information into clinical practice3) Critically evaluate emerging data on novel treatments strategies and their role in expanding the armamentarium in melanoma treatment4) Implement appropriate screening and surveillance strategies for survivors and the at-risk population5) Increase their understanding and management of rarer cutaneous cancers such as Merkel Cell Carcinoma
Roswell Park Cancer Institute is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
Roswell Park Cancer Institute designates this live educational activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ACKNOWLEDGEMENTThis program is supported in part by Prometheus Laboratories, Inc.
Saturday, April 13, 2013 8:30 AM - 3:30 PM
Buffalo Niagara Marriott1340 Millersport HighwayAmherst, NY 14221716-689-6900
John Kane, III, MD
Cvent Online Event Registration Software | Copyright © 2000-2013 Cvent Inc. All rights reserved.